Légende
: Essai en cours de recrutement = 
; Essai en cours = 
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- CLIPPER: A 2-Part Open-Label Study to Assess the Clinical Benefit and Long-Term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, or Psoriatic Arthritis (Phase III) (completed)
- Not yet identified - ES
- Plus de détails
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- CLIPPER2: An Open-label Extension Study to Assess the Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-related Arthritis, Or Psoriatic Arthritis Who Were Previously Enrolled in Protocol 0881A1-3338-ww (Phase II-III) - ES
- Not yet identified - ES
- Plus de détails
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Evaluation of the Efficacy of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis: Randomized Double-blind Placebo-controlled Trial - FR
- CHU Paris - Hôpital Necker - Enfants Malades
- Département de génétique
- Plus de détails
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Etude de phase III visant à évaluer l'efficacité et la tolérance de l'Abatacept chez des enfants et des adolescents souffrant d'une arthrite juvénile idiopathique polyarticulaire active
- CHU Paris - Hôpital Necker - Enfants Malades
- Unité d'Immunologie-Hématologie et Rhumatologie Pédiatriques
- Plus de détails
-
- FRANCE
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Etude ouverte en 2 parties pour évaluer le bénéfice clinique et la tolérance à long terme de l'étanercept chez les enfants et les adolescents souffrant d'arthrite juvénile idiopathique oligo-articulaire étendue, d'arthrite liée à l'enthésite ou d'arthrite psoriasique.
- Not yet identified - FR
- Plus de détails
-
- ITALIE
- EMILIA ROMAGNA
- NOT YET IDENTIFIED - IT
- A 2-part open-label study to assess the clinical benefit and long-term safety of etanercept in children and adolescents with extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis - IT
- NOT YET IDENTIFIED - IT
- Plus de détails
-
- ITALIE
- EMILIA ROMAGNA
- NOT YET IDENTIFIED - IT
- A 24 week randomized double-blind, placebo controlled withdrawal trial with a 16 week open label lead-in phase, and 64 week open label follow-up, to evaluate the efficacy and safety of tocilizumab in patients with active polyarticular-course juvenile idiopathic arthritis.
- NOT YET IDENTIFIED - IT
- Plus de détails
-
- ITALIE
- EMILIA ROMAGNA
- NOT YET IDENTIFIED - IT
- A 12- week randomized, double blind, placebo - controlled, parallel group, 2- arm study to evaluate the efficacy and safety of tocilizumab in patients with active systemic juvenile idiopathic arthritis (sJIA); with a 92- week single arm open- label extension to examine the long term use of tocilizumab
- NOT YET IDENTIFIED - IT
- Plus de détails
-
- A Randomized, Placebo-controlled Study to Evaluate the Effect of Tocilizumab on Disease Response in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA), With an Open-label Extension to Examine the Long Term Use of Tocilizumab
- IRCCS Ospedale Pediatrico Bambino Gesù
- U.O. di Reumatologia
- Plus de détails
-
- Gastrointestinal side effects of MTX in patients with JIA: Phase III effectiveness multicenter randomized clinical trial in Patients with Juvenile Idiopathic Arthritis and Methotrexate (MTX) related side effects: Psychological Behavioural therapy versus switch to MTX parenteral versus standard of care.
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Afdeling Immunologie en Reumatologie kinderen
- Plus de détails
-
- PAYS-BAS
- Zuid-Holland
- LEIDEN
- BeSt for kids: A randomized clinical intervention trial to test the effectiveness of different treatment strategies in patients with Juvenile Idiopathic Arthritis
- LUMC - Leids Universitair Medisch Centrum
- Afdeling Kindergeneeskunde
- Plus de détails
